Cultured Mesenchymal Stem Cells

Phase 2Cell therapy

UUniversidad Autonoma de Madrid

Cultured Mesenchymal Stem Cells is one of 5 biologic programs targeting Avascular Necrosis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Avascular NecrosisActive, not recruiting

Avascular NecrosisPhase 2

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Avascular Necrosis

#DrugCompanyPhaseTrials

Trental

VValidus Pharmaceuticals

Approved

—2

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

—3

Aquasol E

NNational Eye Institute (NEI)

Phase 3

—4

Cultured Mesenchymal Stem Cells

UUniversidad Autonoma de Madrid

Phase 2

1 5

Pamidronate Disodium

NNational Cancer Institute (NCI)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Healing1 trial

A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union

Completed·UUniversidad Autonoma de Madrid·Phase 3·NCT03325504·46 enrolled

Avascular Necrosis1 trial

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip

Completed·UUniversidad Autonoma de Madrid·Phase 2·NCT02065167·26 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Cultured Mesenchymal Stem Cells. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cultured Mesenchymal Stem Cells compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cultured Mesenchymal Stem Cells. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universidad Autonoma de Madrid company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Cell therapy[2]
Highest Phase: Phase 2[1]
Company: UUniversidad Autonoma de Madrid

Cultured Mesenchymal Stem Cells

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Healing1 trial

Avascular Necrosis1 trial

References

Drug Info

Quick Facts

Related News